Alzheimer's, ADHD, Autism, Brain Injury Treatment, Mood Disorders New Jersey: The NeuroCognitive and Behavioral Institute » mild dementia

Neurim Pharmaceuticals announces first patients’ enrollments in ReCOGNITION

Neurim Pharmaceuticals announces first patients’ enrollments in ReCOGNITION – phase II clinical trial of Piromelatine for mild Alzheimer’s disease Tel Aviv, Israel, September 14, 2016 Neurim Pharmaceuticals (“Neurim”) announced today that the first patients hav
Read More
Call Now Button